Arcturus Therapeutics Ltd. Accounts Receivable
Arcturus Therapeutics Ltd. had Accounts Receivable of $4.46 million as of 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2019-05-13
- 2019-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $4.46M.
- 2018-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $4.48M.
- 2018-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $1.12M.
- 2018-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $1.37M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2019-03-31 | $4.46M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $4.48M 10-Q · filed 2019-05-13 |
| 2018-09-30 | $1.12M 6-K · filed 2018-11-07 |
| 2018-06-30 | $1.37M 6-K · filed 2018-09-28 |
| 2017-12-31 | $480.00K 10-K · filed 2019-03-18 |
| 2016-12-31 | $3.63M 20-F · filed 2018-05-14 |